A pilot study on effects of combination usage of curcumin and melatonin on cisplatin treatment

Yükleniyor...
Küçük Resim

Tarih

2016

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Elsevier Ireland Ltd

Erişim Hakkı

info:eu-repo/semantics/embargoedAccess

Özet

Cisplatin is an antitumor drug widely used in the treatmentof many malignant tumors. And also some studies show thatmelatonin and curcumin have antitumor activity via several mech-anisms including theirs in addition to theirs potent antioxidantactions. This study was performed to evaluate the effect of cur-cumin and melatonin on the cytotoxicity induced by cisplatin inthe human breast cancer cell line (MCF-7). The cells were treatedwith melatonin or cisplatin or curcumin for 24 and 48 h. Cellviability was quantified using the 3-(4,5-dimethyl-2-thiazolyl)-

Açıklama

52nd Congress of the European-Societies-of-Toxicology (EUROTOX) -- SEP 04-07, 2016 -- Seville, SPAIN
WOS: 000402436700390

Anahtar Kelimeler

Pharmacy, Pharmaceutical Toxicology

Kaynak

52nd Congress of the European-Societies-of-Toxicology (EUROTOX)

WoS Q Değeri

Q2

Scopus Q Değeri

Cilt

258

Sayı

Supplement: S

Künye

Özdatlı, Ş., Kaşıkçıoğlu G., Göçmen, E., Rüzgar, M. ve Omurtag, G. (2016). A pilot study on effects of combination usage of curcumin and melatonin on cisplatin treatment. 52nd Congress of the European-Societies-of-Toxicology (EUROTOX) içinde (S132-S133. ss.). Seville, Spain, September 04-07, 2016. https://dx.doi.org/10.1016/j.toxlet.2016.06.1522